-
821
Genetic Variations in the Kir6.2 Subunit (KCNJ11) of Pancreatic ATP-Sensitive Potassium Channel Gene Are Associated with Insulin Response to Glucose Loading and Early Onset of Type 2 Diabetes in Childhood and Adolescence in Taiwan
Published 2014-01-01“…Furthermore, in normal glucose-tolerant children/adolescents, K23 allele carriers had a higher insulin response to oral glucose loading.…”
Get full text
Article -
822
Cardiovascular risk associated with glucagon-like peptide-1 receptor agonists versus other conventional glucose-lowering drugs in patients with type-2 diabetes: protocol for a nationwide observational comparative study in routine care
Published 2025-01-01“…These cohorts will be defined by the combination of glucose-lowering drugs prescribed simultaneously with GLP1-RA and diabetes treatment received over a 6-month period before GLP1-RA initiation. …”
Get full text
Article -
823
Prototype analysis of a low-power, small-scale wearable medical device
Published 2025-01-01Subjects: Get full text
Article -
824
D-ribose-5-phosphate inactivates YAP and functions as a metabolic checkpoint
Published 2025-01-01Subjects: Get full text
Article -
825
-
826
-
827
-
828
Incretin hormone agonists as promising antiobesity drugs - review of literature
Published 2025-01-01Subjects: Get full text
Article -
829
Sleep quality in children with hepatic glycogen storage diseases, a prospective observational pilot study
Published 2025-01-01Subjects: “…continuous glucose monitoring (CGM)…”
Get full text
Article -
830
-
831
The Gut Microbiota-Related Antihyperglycemic Effect of Metformin
Published 2025-01-01Subjects: “…glucose-lowering effect…”
Get full text
Article -
832
Body composition as an indicator of metabolic changes in mice obtained by <i>in vitro</i> fertilization
Published 2023-07-01Subjects: Get full text
Article -
833
-
834
The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP
Published 2025-02-01Subjects: Get full text
Article -
835
-
836
-
837
-
838
The Comparison of the Kidney Effects of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide 1 Agonist-Administered Concomitant with Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
Published 2021-01-01“…Strong evidence exists supporting the utility of sodium glucose cotransporter inhibitors (SGLT2is) for treating not only cardiovascular events but also renal events. …”
Get full text
Article -
839
Comparing the Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists with Sodium-Glucose Cotransporter 2 Inhibitors for Obese Type 2 Diabetes Patients Uncontrolled on Metformin: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Published 2020-01-01“…Compared with SGLT-2is, treatment with GLP-1RAs achieved significant reduced HbA1c by 0.40% (95% CI: −0.54, −0.25; p<0.00001), fasting blood glucose (FBG) by 0.17 mmol/L (95% CI: −0.31, −0.04; p=0.01), and postprandial blood glucose (PBG) by 0.32 mmol/L (95% CI: −0.49, −0.14; p=0.0003) for obese T2D patients uncontrolled on metformin. …”
Get full text
Article -
840